InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Nagendran Sukumar, Director. Officer active across 1 company, notably Taysha Gene Therapies, Inc.. In total, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €142k. Activity tracked since 2 February 2022. The latest transaction was filed on 2 February 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
10,000 shares@ US$8.010.0041% mcap50.0% of flowCommon StockSEC:0001209191-22-006652:0
Ideal exit: 30 Oct 2022 (T+270)
10,000 shares@ US$8.010.0041% mcap100.0% of flowCommon StockSEC:0001209191-22-006652
Ideal exit: 30 Oct 2022 (T+270)
2 of 2 declarations
About Nagendran Sukumar
Sukumar Nagendran serves as a Director at Taysha Gene Therapies, Inc. In this role, he participates in the company's strategic decisions and governance. Nagendran brings expertise in biotechnology and gene therapies, which is crucial for Taysha's innovation. His commitment to excellence and strategic vision are assets to the board.
